Cargando…
A simplified purification protocol for recombinant adeno-associated virus vectors
We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420252/ https://www.ncbi.nlm.nih.gov/pubmed/26015974 http://dx.doi.org/10.1038/mtm.2014.34 |
_version_ | 1782369682425118720 |
---|---|
author | Potter, Mark Lins, Bridget Mietzsch, Mario Heilbronn, Regine Van Vliet, Kim Chipman, Paul Agbandje-McKenna, Mavis Cleaver, Brian D Clément, Nathalie Byrne, Barry J Zolotukhin, Sergei |
author_facet | Potter, Mark Lins, Bridget Mietzsch, Mario Heilbronn, Regine Van Vliet, Kim Chipman, Paul Agbandje-McKenna, Mavis Cleaver, Brian D Clément, Nathalie Byrne, Barry J Zolotukhin, Sergei |
author_sort | Potter, Mark |
collection | PubMed |
description | We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes: (i) low isoelectric point of a capsid and (ii) relative biological stability of the viral particle in the acidic environment. A simple and rapid clarification of cell lysate toremove the bulk of proteins and DNA is accomplished by utilizing inexpensive off-the-shelf reagents such as sodium citrate and citric acid. After the low-speed centrifugation step, the supernatant is subjected to cation exchange chromatography via sulfopropyl (SP) column. The eluted virus may then be further concentrated by either centrifugal spin devices or tangential flow filtration yielding material of high titer and Good Manufacturing Practice (GMP) grade biochemical purity. The protocol is validated for rAAV serotypes 2, 8, and 9. The described method makes rAAV vector technology readily available for the low budget research laboratories and could be easily adapted for a large scale GMP production format. |
format | Online Article Text |
id | pubmed-4420252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-44202522015-05-26 A simplified purification protocol for recombinant adeno-associated virus vectors Potter, Mark Lins, Bridget Mietzsch, Mario Heilbronn, Regine Van Vliet, Kim Chipman, Paul Agbandje-McKenna, Mavis Cleaver, Brian D Clément, Nathalie Byrne, Barry J Zolotukhin, Sergei Mol Ther Methods Clin Dev Article We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes: (i) low isoelectric point of a capsid and (ii) relative biological stability of the viral particle in the acidic environment. A simple and rapid clarification of cell lysate toremove the bulk of proteins and DNA is accomplished by utilizing inexpensive off-the-shelf reagents such as sodium citrate and citric acid. After the low-speed centrifugation step, the supernatant is subjected to cation exchange chromatography via sulfopropyl (SP) column. The eluted virus may then be further concentrated by either centrifugal spin devices or tangential flow filtration yielding material of high titer and Good Manufacturing Practice (GMP) grade biochemical purity. The protocol is validated for rAAV serotypes 2, 8, and 9. The described method makes rAAV vector technology readily available for the low budget research laboratories and could be easily adapted for a large scale GMP production format. Nature Publishing Group 2014-08-13 /pmc/articles/PMC4420252/ /pubmed/26015974 http://dx.doi.org/10.1038/mtm.2014.34 Text en Copyright © 2014 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Article Potter, Mark Lins, Bridget Mietzsch, Mario Heilbronn, Regine Van Vliet, Kim Chipman, Paul Agbandje-McKenna, Mavis Cleaver, Brian D Clément, Nathalie Byrne, Barry J Zolotukhin, Sergei A simplified purification protocol for recombinant adeno-associated virus vectors |
title | A simplified purification protocol for recombinant adeno-associated virus vectors |
title_full | A simplified purification protocol for recombinant adeno-associated virus vectors |
title_fullStr | A simplified purification protocol for recombinant adeno-associated virus vectors |
title_full_unstemmed | A simplified purification protocol for recombinant adeno-associated virus vectors |
title_short | A simplified purification protocol for recombinant adeno-associated virus vectors |
title_sort | simplified purification protocol for recombinant adeno-associated virus vectors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420252/ https://www.ncbi.nlm.nih.gov/pubmed/26015974 http://dx.doi.org/10.1038/mtm.2014.34 |
work_keys_str_mv | AT pottermark asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT linsbridget asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT mietzschmario asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT heilbronnregine asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT vanvlietkim asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT chipmanpaul asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT agbandjemckennamavis asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT cleaverbriand asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT clementnathalie asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT byrnebarryj asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT zolotukhinsergei asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT pottermark simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT linsbridget simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT mietzschmario simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT heilbronnregine simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT vanvlietkim simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT chipmanpaul simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT agbandjemckennamavis simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT cleaverbriand simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT clementnathalie simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT byrnebarryj simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors AT zolotukhinsergei simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors |